Extended Fused Carbazole‐BODIPY, High Brightness NIR Organic Dyes
Angewandte Chemie International Edition · 20.04.2026 · 65 (17)
DOI: 10.1002/anie.202526011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.03.2026. Verfasst von Fabien Ceugniet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut De Chimie et Procédés Pour L'energie, L'environnement Et La Santé (ICPEES), CNRS UMR 7515, École De Chimie Polymères, Matériaux De Strasbour…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, France Life Imaging.
Abstract (Originalsprache)
Fluorescence‐based bioimaging enables noninvasive visualization of molecular and cellular processes with high sensitivity and without ionizing radiation. However, conventional fluorophores emitting in the visible or near‐red infrared I (NIR‐I) (650–800 nm) regions suffer from limited tissue penetration and scattering. Extending fluorescence emission into the deeper NIR region represents a promising strategy to overcome these drawbacks, yet achieving high brightness and stability in organic dyes remains a major challenge. We report an original family of hetero‐substituted‐fused boron‐dipyrromethene (BODIPY) dyes bearing carbazole and thienyl donors that exhibit record brightness and emission maxima up to 852 nm in toluene. The synthetic route combines successive Stille couplings from a 2,6‐dibromo‐3,5‐diiodo‐BODIPY precursor and an unprecedented silver(I)‐mediated oxidative cyclization, affording high yields and suppressing undesired chlorination. The resulting dyes display intense absorption ( ε = 1.8–2.5 × 10 5 M − 1 cm − 1 ) and exceptional fluorescence quantum yields ( Φ up to 0.73). Encapsulation in silica nanoparticles (NPs) preserves their photophysical properties and enables efficient NIR‐II in vivo imaging in mice, allowing tumor detection at doses as low as 0.2 nmol with tumor‐to‐muscle ratios > 4. These fused BODIPY derivatives rank among the brightest NIR fluorophores reported to date and open new avenues for high‐contrast deep‐tissue imaging and image‐guided surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut De Chimie et Procédés Pour L'energie, L'environnement Et La Santé (ICPEES), CNRS UMR 7515, École De Chimie Polymères, Matériaux De Strasbourg (ECPM), Strasbourg, Cedex, France.
- Service De Cristallographie Structurale, ICSN-CNRS Université Paris-Saclay, Gif-sur-Yvette, Cedex, France.
- LCH, UMR 5182 CNRS-ENS Lyon-Université Lyon I, France.
- Nantes Université, CNRS, CEISAM, Nantes, France.
- Université Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institute For Advanced Biosciences, Grenoble, France.
- Institut Universitaire de France (IUF), Paris, France.
ORCID-Profile: Pascal Retailleau, Yann Bretonniere, Olivier Maury, Lucie Sancey, Nicolas Leclerc, Denis Jacquemin, Gilles Ulrich
Förderung
- Agence Nationale de la Recherche
- France Life Imaging
Zitieren
APA
Ceugniet, F., Ott, V., Retailleau, P., Bretonniere, Y., Maury, O., Bousquet, M. H. E., Sancey, L., Leclerc, N., Jacquemin, D., & Ulrich, G. (2026). Extended Fused Carbazole‐BODIPY, High Brightness NIR Organic Dyes. Angewandte Chemie International Edition, 65(17). https://doi.org/10.1002/anie.202526011
Vancouver
Ceugniet F, Ott V, Retailleau P, Bretonniere Y, Maury O, Bousquet MHE, et al. Extended Fused Carbazole‐BODIPY, High Brightness NIR Organic Dyes. Angewandte Chemie International Edition. 2026;65(17). doi:10.1002/anie.202526011
BibTeX
@article{Ceugniet2026,
author = {Ceugniet, Fabien and Ott, Valentin and Retailleau, Pascal and Bretonniere, Yann and Maury, Olivier and Bousquet, Manon H E and Sancey, Lucie and Leclerc, Nicolas and Jacquemin, Denis and Ulrich, Gilles},
title = {Extended Fused Carbazole‐BODIPY, High Brightness NIR Organic Dyes},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {17},
doi = {10.1002/anie.202526011}
}
EUVIMED